Jazz Pharmaceuticals Plc Asset Turnover Ratio (JAZZ), as of third quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Jazz Pharmaceuticals Plc  (NASDAQ: JAZZ)
 

Jazz Pharmaceuticals Plc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Jazz Pharmaceuticals Plc asset turnover ratio, the ability of Jazz Pharmaceuticals Plc's assets to generate revenue in the third quarter 2026, increased sequentially to 0.41 in the third quarter (Sep 30 2026), JAZZ's balance sheet remain strong.

Within sector 94 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Third Quarter 2026 compared to the preceding quarter from 2279 to 2371.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

JAZZ Asset Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Asset Change 5.65 % 1.25 % 2.82 % 1.99 % -2.72 %
Y / Y Revenue Change 10.38 % 15.55 % 19.05 % 10.09 % 6.74 %
Asset Turnover Ratio (TTM) 0.41 0.4 0.39 0.38 0.37
JAZZ's Total Ranking # 2371 # 2279 # 1584 # 2246 #
Seq. Asset Change 8.27 % -6.57 % 1.72 % 2.67 % 3.77 %
Seq. Revenue Change 2.87 % 13.04 % -10.77 % 6.38 % 7.69 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 95
Healthcare Sector # 336
Overall Market # 2371

Asset Turnover Ratio Statistics
High Average Low
1.38 0.39 0.27
(Dec 31 2011)   (Mar 31 2022)




JAZZ Company Profile • Back to JAZZ Efficiency Comparisons • Compare JAZZ Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2026 Assets at quarter ending Sep 30 2026
Corcept Therapeutics Inc  1.08 $ 963.647  Millions$ 893.565  Millions
Cerus Corporation  1.06 $ 226.798  Millions$ 213.671  Millions
Alphatec Holdings Inc   1.06 $ 839.652  Millions$ 794.614  Millions
Mimedx Group Inc   1.01 $ 303.363  Millions$ 299.220  Millions
Pacs Group Inc   1.00 $ 5,705.049  Millions$ 5,705.514  Millions
Caredx Inc   1.00 $ 497.396  Millions$ 499.684  Millions
Ensign Group Inc  0.99 $ 5,674.305  Millions$ 5,705.629  Millions
Fortrea Holdings Inc   0.98 $ 2,666.700  Millions$ 2,713.050  Millions
Orthofix Medical Inc   0.96 $ 835.683  Millions$ 866.507  Millions
Exelixis Inc   0.96 $ 2,496.861  Millions$ 2,611.435  Millions
Inspire Medical Systems inc   0.95 $ 882.194  Millions$ 924.430  Millions
Travere Therapeutics Inc   0.93 $ 651.034  Millions$ 701.992  Millions
Community Health Systems Inc   0.92 $ 11,653.000  Millions$ 12,667.250  Millions
Nurix Therapeutics Inc   0.92 $ 701.936  Millions$ 763.776  Millions
Pediatrix Medical Group Inc   0.91 $ 1,959.124  Millions$ 2,146.688  Millions
Novocure Limited  0.90 $ 725.388  Millions$ 804.038  Millions
Si bone inc   0.90 $ 222.189  Millions$ 246.700  Millions
Phathom Pharmaceuticals Inc   0.89 $ 274.881  Millions$ 309.091  Millions
Teladoc Health Inc   0.88 $ 2,468.143  Millions$ 2,799.815  Millions
Lensar Inc   0.88 $ 60.079  Millions$ 68.570  Millions
Bioventus Inc   0.87 $ 585.319  Millions$ 670.219  Millions
Ardelyx inc   0.86 $ 468.220  Millions$ 542.382  Millions
Encompass Health Corporation  0.86 $ 6,338.100  Millions$ 7,356.725  Millions
Alpha Pro Tech Ltd   0.86 $ 64.940  Millions$ 75.551  Millions
Carlisle Companies Incorporated  0.85 $ 5,213.500  Millions$ 6,129.300  Millions
Alnylam Pharmaceuticals Inc   0.85 $ 5,013.242  Millions$ 5,912.330  Millions
Trisalus Life Sciences Inc   0.84 $ 47.397  Millions$ 56.580  Millions
West Pharmaceutical Services Inc   0.82 $ 3,397.100  Millions$ 4,129.225  Millions
Protalix Biotherapeutics inc   0.82 $ 84.693  Millions$ 103.315  Millions
Incyte Corporation  0.82 $ 6,010.754  Millions$ 7,364.247  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.